Micro-cap stock that is engaged in the manufacturing and supplying of fiber-reinforced polymer products jumped 12 percent in the day’s trade after it received a work order worth Rs. 72.28 Lakhs from Oil and Natural Gas Corporation Limited (ONGC). 

At 1:30 p.m. the shares of EP Biocomposites Limited were trading at Rs. 225, up 11 percent from its previous day’s close price of Rs. 203 and its market capitalization is Rs. 450 Crores. 

EP Biocomposites Limited has received an order worth Rs. 72.28 Lakhs, from Oil and Natural Gas Corporation Limited (ONGC) for the design, supply, installation, testing, and commissioning of a sewage treatment plant (STP) of 100 KLD capacity (MBR-based) including civil and electrification work with all necessary utilities. 

The prestigious order from ONGC represents around 10 percent of the company’s entire turnover from the previous financial year 2022-23 and is proposed to be completed within financial year 2023-24. 

The company’s revenue from operations decreased by 11.54 percent from Rs. 8.06 Crore in FY22 to Rs. 7.13 Crore in FY23, accompanied by profits of Rs. 0.81 Crore to Rs. 0.58 Crore. 

It has reported a return on equity (ROE) of 11.07 percent and a return on capital employed (ROCE) of 13.21 percent, it is making decent returns on its equity and capital employed. 

According to the latest shareholding data available for the September 2023 quarter, the Promoters of the company hold 70.08 percent stake, the Foreign Institutional Investors (FII) hold 2.20 percent and the Domestic Institutional Investors hold 0.00 percent. 

EP Biocomposites is engaged in the manufacturing and supplying of fiber-reinforced polymer products such as door shutters, frames, Biodigestor Tanks, Bio toilets, and allied products for construction and Industrial applications. It also offers solutions related to sewage treatments and sanitation works.

Written by Bharath KS


The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.